Woman researcher looking at test tube samples for clinical research study.

Clinical Research

Today’s Commitment. Tomorrow’s Cure.

Prism Health North Texas launched its Clinical Research Program in 2006 when the Peabody Health Center became a network clinical research site (CRS) for the National Institutes of Health’s (NIH) AIDS Clinical Trials Group (ACTG). From 2006 to 2025, we proudly served as an ACTG site, contributing to groundbreaking research and advancing care for people living with HIV.

In 2007, we expanded our commitment to innovative research by partnering with pharmaceutical companies to conduct industry-sponsored clinical trials. These collaborations have allowed us to broaden our focus to include HIV and other communicable diseases, and we continue to grow our efforts in clinical research today. Although we are no longer a CRS for the NIH as of 2025, our dedication to improving health outcomes through clinical trials remains stronger than ever.

PHNTX conducted clinical trials which have led to the FDA approval and/or expanded indications for 8 medications: Biktarvy, Pifeltro, Delstrigo, Cabenuva, Apretude, Trogarzo, Dovato, and Sunlenca.

If you have questions about PHNTX’s clinical research, you can explore the Frequently Asked Questions section on this page, call our main line at 214-521-5191 and ask to be transferred to the clinical research department, or email us at [email protected].

Featured Study

This clinical research study is seeking adults aged 18 and over, both with and without STI symptoms, who are sexually active and haven’t recently used antibiotics (except for Doxy PEP) or topical rectal products. Participation involves a confidential visit of around 45 minutes at Prism Health North Texas, Oak Cliff Health Center, where volunteers will provide throat and rectal swabs and discuss sexual exposures.

Need more information? Learn more about the Sexually Transmitted Infection Diagnostic Study here.

Research Participant Interest Form
Black gay couple hugging

Types of Clinical Research Studies

Interventional Studies

Participants are assigned to groups that receive one or more treatments (or no treatment). Researchers actively provide the treatments, often assigned randomly.

  • Examples: new drugs, vaccines, medical devices, or procedures.

Observational Trials

Researchers observe participants without changing their medical care.

  • Focuses on risk factors, outcomes, or results of diagnostic tests and questionnaires.

Frequently Asked Questions

Community Advisory Board

The Research Program has an active Community Advisory Board (CAB) dedicated to community outreach and peer education. The CAB is made up of five men and two women who are passionate about HIV research, treatment, and prevention. The CAB meets every other month and reviews studies in the early phase of development to provide community feedback on the study’s design, which helps the sponsor improve study objectives, potential recruitment, and participant retention. The CAB also provides input on ways to recruit participants and keep them engaged while participating in a study.

a female researcher in a protective cap, eyewear and latex gloves holding a pill capsule with tweezers and examining it closely - clinical research trials dallas hiv

Help Us Make Medical Progress

Express interest in participating in a clinical research study by filling out our online interest form. If you have questions, call our main line at 214-521-5191 or email us at [email protected], and ask to be transferred to the clinical research department.